1-4 of 4
Michelle Carraher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long Term Survival After Sirolimus Based Non-Ablative Alternative Donor Transplantation.

Jon Karch, BSc, Eric Schaefer, M.A., W. Chritopher Ehmann, MD, Michelle Carraher, BA, Giampaolo Talamo, MD, Witold B Rybka, MD, David F. Claxton, M.D.
Journal: Blood
Blood (2009) 114 (22): 1212.
https://doi.org/10.1182/blood.V114.22.1212.1212
Published: 2009
Journal Articles

Sirolimus for Graft-Versus-Host-Diseases Prophylaxis in Non-Myeloablative Matched Related Transplantation: Safety and Efficacy.

Hong Zheng, MD, PhD, Michelle Carraher, BA, Eric Schaefer, M.A., Giampaolo Talamo, MD, W. Christopher Ehmann, MD, Witold Rybka, David F. Claxton, M.D.
Journal: Blood
Blood (2009) 114 (22): 4329.
https://doi.org/10.1182/blood.V114.22.4329.4329
Published: 2009
Journal Articles

G-CSF Mobilized Versus Conventional Donor Lymphocytes in the Treatment of Hematological Malignancies.

Kamal K.S. Abbi, M.D., W. Chritopher Ehmann, MD, Giampaolo Talamo, MD, Kenneth Lucas, MD, Michelle Carraher, BA, Witold Rybka, M.D., David F. Claxton
Journal: Blood
Blood (2009) 114 (22): 4301.
https://doi.org/10.1182/blood.V114.22.4301.4301
Published: 2009
Journal Articles

Non-Myeloablative Hematopoietic Transplant with Sirolimus Immunosuppression: Determinants of Outcome.

David F. Claxton, MD, Chuancai Wang, PhD, Michelle Carraher, Christopher Ehmann, MD, Witold Rybka, MD
Journal: Blood
Blood (2005) 106 (11): 5462.
https://doi.org/10.1182/blood.V106.11.5462.5462
Published: 2005